David Moadel

David Moadel

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

If You Invested $1,000 in MSFT Stock 3 Years Ago, Here’s What You’d Have Today!

MSFT stock's post-pandemic rebound is a textbook example of why investors should stay the course with great companies.

Floki Inu Price Predictions: Where Will the FLOKI Crypto Go in 2023?

A variety of Floki Inu price predictions might add clarity in the fast-moving world of dog-themed crypto coins.

George Soros Is Betting on Carvana Stock. That’s a Mistake.

Just because a billionaire bought CVNA stock, doesn't mean you have to invest in an unprofitable and lawsuit-prone business like Carvana.

Jeffs’ Brands (JFBR) Stock Gains 7% on AI Collaboration With SuperBuzz

JFBR stock is heading higher as Jeffs' Brands deploys machine learning to ramp up its marketing efforts on Amazon.

Alphabet Is Snapping Up GOOG Stock. Should You?

An imminent legal threat to Google's online advertising business means it's time to exercise caution with GOOG stock.

Chemomab (CMMB) Stock Gains 30% on FDA Clearance

Chemomab's regulatory win means the company can take the next step in a clinical trial, so CMMB stock traders are in celebration mode today.

Why Is DocuSign (DOCU) Stock Down 8% Today?

After a substantial run-up, DOCU stock could decline sharply. Or, at least that's what a group of analysts expects to happen.

Will RIDE Stock Ever Recover? Here’s My Take.

RIDE stock moved higher in early 2023, but that rally isn't likely to persist throughout the year as Lordstown slowly ramps up EV production.

My Lucid (LCID) Stock Price Prediction for 2025

The long-term outlook for LCID stock won't be great as Lucid's vehicles will still be expensive even after a $7,500 credit.

If You Invested $1,000 in Apple Stock 1 Year Ago, Here’s What You’d Have Today!

AAPL stock had an unusually lackluster year, but this was just a runway to a rally as Apple integrates AI into its products.